SWOG clinical trial number
SWOG-8991 (EST-3588) (RTOG-8815) (INT-0096)

A Phase III Study of Cisplatin plus Etoposide Combined with Standard Fractionation Thoracic Radiotherapy vs Cisplatin plus Etoposide Combined with Multiple Daily Fractionated Thoracic Radiotherapy for Limited Stage Small Cell Lung Cancer

Closed
Phase
Published
Abbreviated Title
A Phase III Study of Cisplatin plus Etoposide Combined with Standard Fractionation Thoracic Radiotherapy vs Cisplatin plus Etoposide Combined with Multiple Daily Fractionated Thoracic Radiotherapy…
Activated
02/15/1990
Closed
08/01/1992

Research committees

Lung Cancer

Publication Information Expand/Collapse

1999

Twice-daily compared with once-daily thoracic radiotherapy in limited small cell lung cancer treated concurrently with cisplatin and etoposide

AT Turrisi;K Kim;R Blum;WT Sause;RB Livingston;R Komaki;H Wagner;S Aisner;DH Johnson New England Journal of Medicine 340(4):265-271

1998

Observations after 5 year follow-up of intergroup trial 0096: 4 cycles of cisplatin(P) etoposide (E) and concurrent 45 GY thoracic radiotherapy (TRT) given in daily (QD) or twice-daily fractions followed by 25 GY PCI. Survival differencs and patterns of failure.

A Turrisi;K Kim;W Sause;R Komaki;H Wagner;S Aisner;R Livingston;R Blum;D Johnson Proc of the American Society of Clinical Oncology 17:457a(#1757

Incidence and clinical significance of variant morphology (small cell/large cell subtype) in limited stage small cell lung cancer (SCLC). A prospective analysis of an intergroup ECOG, RTOG and SWOG study.

SC Aisner;A Turrisi;KM Kim;WT Sause;RB Livingston;L Einhorn;H Wagner;D Ettinger;R Komaki;R Blum;DH Johnson Proc of the American Society of Clinical Oncology 17:458a(#1764)

Other Clinical Trials

SWOG Clinical Trial Number
CTSU/EA5231

A Randomized Phase III Trial of Checkpoint Blockade in Lung Cance3r Patients in the Adjuvant Setting Based on Pathologic Response Following Neoadjuvant Therapy (CLEAR)
Research Committee(s)
Lung Cancer
Activated
06/13/2025
Open
SWOG Clinical Trial Number
S2414

INcorporating pathologic reSponse in patIents with early staGe lung cancer to optimize immunotHerapy in the adjuvanT setting (INSIGHT)
Research Committee(s)
Lung Cancer
Symptom Control and Quality of Life
Activated
03/14/2025
Accrual
2%
Open
Phase
SWOG Clinical Trial Number
CTSU/A082304/S2402

Perioperative Versus Adjuvant Systemic Therapy In Patients with Resectable Non-Small Cell Lung Cancer - PROSPECT LUNG, CTIU2317
Research Committee(s)
Lung Cancer
Activated
12/11/2024
Open